Stay updated on Pembrolizumab+Cabozantinib in Metastatic Renal Cell Carcinoma Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab+Cabozantinib in Metastatic Renal Cell Carcinoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab+Cabozantinib in Metastatic Renal Cell Carcinoma Clinical Trial page

  1. Check
    7 days ago
    Change Detected
    Summary
    The study page now displays a 403 Forbidden error, replacing the usual study details with an error screen. A Home button is provided to navigate away from the blocked page.
    Difference
    21%
    Check dated 2026-09-23T00:51:41.000Z thumbnail image
  2. Check
    14 days ago
    Change Detected
    Summary
    Revision number updated from v3.6.6 to v3.7.0, indicating a new page version and routine maintenance. This change does not modify study content, eligibility criteria, or any user-facing information on the page.
    Difference
    0.0%
    Check dated 2026-09-16T00:08:20.000Z thumbnail image
  3. Check
    21 days ago
    No Change Detected
  4. Check
    28 days ago
    Change Detected
    Summary
    The page's revision label was updated from v3.6.5 to v3.6.6, indicating a minor update to the Study Details page. This reflects a page metadata revision rather than modifications to the study data or eligibility criteria.
    Difference
    0.0%
    Check dated 2026-09-01T19:31:59.000Z thumbnail image
  5. Check
    49 days ago
    Change Detected
    Summary
    The page’s revision tag was updated from v3.6.4 to v3.6.5, indicating a newer release of the study details page. The visible content remains unchanged; the change reflects an internal version update.
    Difference
    0.0%
    Check dated 2026-08-11T18:02:40.000Z thumbnail image
  6. Check
    63 days ago
    Change Detected
    Summary
    The page's revision history now shows a new version, v3.6.4, superseding the previous v3.6.3. This indicates a backend/content update to the page rather than changes to the study details or results.
    Difference
    0.0%
    Check dated 2026-07-28T14:58:53.000Z thumbnail image
  7. Check
    92 days ago
    Change Detected
    Summary
    The page's revision tag was updated from v3.6.0 to v3.6.3, signaling a newer version of the study record. This update appears to be a metadata revision rather than a change to study content or functionality.
    Difference
    0.0%
    Check dated 2026-06-30T02:14:58.000Z thumbnail image

Stay in the know with updates to Pembrolizumab+Cabozantinib in Metastatic Renal Cell Carcinoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab+Cabozantinib in Metastatic Renal Cell Carcinoma Clinical Trial page.